These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 9280483

  • 21. Taurine fails to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion in mice.
    Navneet AK, Appukuttan TA, Pandey M, Mohanakumar KP.
    Amino Acids; 2008 Aug; 35(2):457-61. PubMed ID: 17701098
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H, Aimi Y, Nagatsu I, Taki K, Kudo M, Arai R.
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [Abstract] [Full Text] [Related]

  • 23. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 24. Adrenal medulla and Parkinson's disease.
    Stoddard SL, Merkel GJ, Cook JA, Zinsmeister AR, Carmichael SW.
    Microsc Res Tech; 1994 Oct 01; 29(2):151-4. PubMed ID: 7812036
    [Abstract] [Full Text] [Related]

  • 25. [The effect of haloperidol at a low dose on the development of experimental parkinsonian syndrome].
    Korshunov AM, Voronina TA, Churiukanov VV, Iakhno NN.
    Eksp Klin Farmakol; 1995 Oct 01; 58(6):7-9. PubMed ID: 8704620
    [Abstract] [Full Text] [Related]

  • 26. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 01; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 27. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1999 Feb 01; 155(2):204-20. PubMed ID: 10072296
    [Abstract] [Full Text] [Related]

  • 28. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
    Rojo AI, Cavada C, de Sagarra MR, Cuadrado A.
    Exp Neurol; 2007 Nov 01; 208(1):120-6. PubMed ID: 17880941
    [Abstract] [Full Text] [Related]

  • 29. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M.
    J Neurosci Res; 2007 Jun 01; 85(8):1752-61. PubMed ID: 17469135
    [Abstract] [Full Text] [Related]

  • 30. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y.
    Eur J Neurosci; 2009 Mar 01; 29(5):891-900. PubMed ID: 19245369
    [Abstract] [Full Text] [Related]

  • 31. Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease.
    Kurkowska-Jastrzebska I, Litwin T, Joniec I, Ciesielska A, Przybyłkowski A, Członkowski A, Członkowska A.
    Int Immunopharmacol; 2004 Oct 01; 4(10-11):1307-18. PubMed ID: 15313429
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice.
    Muroyama A, Inaka M, Matsushima H, Sugino H, Marunaka Y, Mitsumoto Y.
    Neurosci Res; 2009 Jan 01; 63(1):72-5. PubMed ID: 18977253
    [Abstract] [Full Text] [Related]

  • 34. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS, Starr MS.
    Synapse; 1999 Oct 01; 34(1):36-46. PubMed ID: 10459170
    [Abstract] [Full Text] [Related]

  • 35. Neuroprotective aspects of a novel MAO-B inhibitor PF9601N.
    Pérez V, Morón J, Pastó M, Unzeta M.
    Neurobiology (Bp); 2000 Oct 01; 8(3-4):231-6. PubMed ID: 11225513
    [Abstract] [Full Text] [Related]

  • 36. The effect of intrastriatal injection of liposome-entrapped tyrosinase on the dopamine levels in the rat brain.
    Amicarelli F, Gasbarri A, Masciocco L, Pompili A, Pacitti C, Carlucci G, Palumbo G, Miranda M.
    Cell Mol Biol (Noisy-le-grand); 1999 Nov 01; 45(7):1093-7. PubMed ID: 10644014
    [Abstract] [Full Text] [Related]

  • 37. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
    Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M.
    Brain; 2008 Dec 01; 131(Pt 12):3380-94. PubMed ID: 18952677
    [Abstract] [Full Text] [Related]

  • 38. MPTP-induced parkinsonian model in mice: biochemistry, pharmacology and behavior.
    Ogawa N, Mizukawa K, Hirose Y, Kajita S, Ohara S, Watanabe Y.
    Eur Neurol; 1987 Dec 01; 26 Suppl 1():16-23. PubMed ID: 2884111
    [Abstract] [Full Text] [Related]

  • 39. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset.
    Pearce RK, Banerji T, Jenner P, Marsden CD.
    Mov Disord; 1998 Mar 01; 13(2):234-41. PubMed ID: 9539335
    [Abstract] [Full Text] [Related]

  • 40. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
    Mori A, Ohashi S, Nakai M, Moriizumi T, Mitsumoto Y.
    Neurosci Res; 2005 Mar 01; 51(3):265-74. PubMed ID: 15710490
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.